2023 - Research.com Medicine in Australia Leader Award
2018 - Fellow of the Australian Academy of Health and Medical Science
2006 - Fellow of the Australian Academy of Science
His primary areas of investigation include Internal medicine, Endocrinology, Cardiology, Endothelium and Endothelial dysfunction. David S. Celermajer regularly ties together related areas like Surgery in his Internal medicine studies. The various areas that David S. Celermajer examines in his Surgery study include Heart disease, Pediatrics, Sudden death and Confidence interval.
His work is dedicated to discovering how Cardiology, Blood pressure are connected with Intima-media thickness and Continuous positive airway pressure and other disciplines. David S. Celermajer interconnects Endothelial stem cell, Meal, Immunology, Nitric oxide and Vasodilation in the investigation of issues within Endothelium. He combines subjects such as Crossover study, Pathogenesis, Gastroenterology, Arteriosclerosis and Vascular smooth muscle with his study of Endothelial dysfunction.
The scientist’s investigation covers issues in Internal medicine, Cardiology, Endocrinology, Surgery and Heart disease. His research in Endothelium, Blood pressure, Endothelial dysfunction, Pulmonary hypertension and Hemodynamics are components of Internal medicine. Many of his studies on Endothelial dysfunction involve topics that are commonly interrelated, such as Vascular disease.
His study in the fields of Tetralogy of Fallot, Ventricle, Heart failure and Pulmonary artery under the domain of Cardiology overlaps with other disciplines such as In patient. His Endocrinology and Androgen, Cholesterol, Lipoprotein, Diabetes mellitus and Brachial artery investigations all form part of his Endocrinology research activities. His Heart disease study integrates concerns from other disciplines, such as Pediatrics and Intensive care medicine.
His primary areas of study are Internal medicine, Cardiology, Heart disease, Cohort and Heart failure. His study in Confidence interval, Pulmonary hypertension, Ejection fraction, Disease and Tetralogy of Fallot is carried out as part of his Internal medicine studies. His Confidence interval research focuses on Meta-analysis and how it relates to MEDLINE.
His Cardiology study frequently draws parallels with other fields, such as Diastole. His Heart disease study combines topics in areas such as Coarctation of the aorta, Adverse effect, Pediatrics and Intensive care medicine. His Fontan procedure research includes themes of Propensity score matching, Risk factor, Heterotaxy and Heart transplantation.
His scientific interests lie mostly in Internal medicine, Cardiology, Heart disease, Heart failure and Pulmonary hypertension. His work in Internal medicine tackles topics such as Endocrinology which are related to areas like Clinical trial. His studies deal with areas such as Meta-analysis, Adverse effect and Severity of illness as well as Cardiology.
His study in Heart disease is interdisciplinary in nature, drawing from both Bosentan, Pediatrics, Improved survival and Intensive care medicine. His study in the field of Exercise intolerance is also linked to topics like Medical care. The Pulmonary hypertension study combines topics in areas such as Central venous pressure, Hemodynamics, Vascular resistance, Vascular disease and Pulmonary artery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
D.S. Celermajer;K.E. Sorensen;V.M. Gooch;D.J. Spiegelhalter.
The Lancet (1992)
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force
Mary C Corretti;Todd J Anderson;Emelia J Benjamin;David Celermajer.
Journal of the American College of Cardiology (2002)
Updated Clinical Classification of Pulmonary Hypertension
Gerald Simonneau;Michael A Gatzoulis;Ian Adatia;David Celermajer.
Journal of the American College of Cardiology (2009)
Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
Gérald Simonneau;Gérald Simonneau;David Montani;David Montani;David S. Celermajer;Christopher P. Denton.
European Respiratory Journal (2019)
Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults.
David S. Celermajer;Keld E. Sorensen;Dimitri Georgakopoulos;Catherine Bull.
Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction☆
David S. Celermajer;Keld E. Sorensen;Catherine Bull;Jacqui Robinson.
Journal of the American College of Cardiology (1994)
Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women
David S. Celermajer;Keld E. Sorensen;David J. Spiegelhalter;Dimitri Georgakopoulos.
Journal of the American College of Cardiology (1994)
Passive Smoking and Impaired Endothelium-Dependent Arterial Dilatation in Healthy Young Adults
David S. Celermajer;Mark R. Adams;Peter Clarkson;Jacqui Robinson.
The New England Journal of Medicine (1996)
The Assessment of Endothelial Function From Research Into Clinical Practice
Andreas J. Flammer;Todd Anderson;David S. Celermajer;Mark A. Creager;Mark A. Creager.
Endothelial dysfunction: does it matter? Is it reversible?
David S Celermajer.
Journal of the American College of Cardiology (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: